Group B Streptococcus (GBS) Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Group B Streptococcus (GBS) Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06833957

Preparing for Maternal GBS Vaccine Trials in Africa

Infections are one of the key causes of newborn deaths. Among them, Group B Streptococcus (GBS) is the leading cause of sepsis and bacterial meningitis in the f…

Kenya, Malawi18,100 participantsStarted 2025-03-01

All recent trials (25 shown)

Active — Not RecruitingPhase 2/3

NCT06592586

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

The main objective of the study is to evaluate the persistence of the immunoglobulin G (IgG) antibody responses, specific to Alpha-like protein CN (AlpCN), Ribo…

Denmark, South Africa338 participantsStarted 2025-03-07

Treatment: GBS-NN/NN2 vaccine

CompletedNot Applicable

NCT02471937

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

Streptococcus agalactiae (GBS) is the leading cause of neonatal septicaemia, meningitis, and pneumonia in the industrialized world. Early onset (EOD) and late o…

France151 participantsStarted 2015-06-01

Treatment: Bacteriological analyses on clinical samples performed with Eswabs

Group B Streptococcus (GBS) Disease

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Preparing for Maternal GBS Vaccine Trials in Africa

All recent trials (25 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Preparing for Maternal GBS Vaccine Trials in Africa

All recent trials (25 shown)

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

Interest of the Detection of Hyper-virulent Clone ST17 of Group B Strep (GBS) for the Prevention of Neonatal GBS Meningi…

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Group B Streptococcus Infection and PROM Incidince

Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting

Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Probiotics and GBS Colonization in Pregnancy

Group B Streptococcus Colonization in Mother-newborn Dyads and Association With Serotype-specific Capsular Antibodies in…

Probiotic on Prevention of GBS Vaginal Infection During Pregnancy

Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women

QF-PCR In GBS Diagnosis During Pregnancy

A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease…

Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis

GBS Sero-correlate of Protection

A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF